130 related articles for article (PubMed ID: 34153685)
1. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
Nakatani K; Asai O; Konishi N; Iwano M
Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
[TBL] [Abstract][Full Text] [Related]
4. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
[TBL] [Abstract][Full Text] [Related]
5. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis.
Hu H; Li M; Chen B; Guo C; Yang N
Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
7. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
10. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
[TBL] [Abstract][Full Text] [Related]
11. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
[TBL] [Abstract][Full Text] [Related]
12. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
[TBL] [Abstract][Full Text] [Related]
14. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
15. C-C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis.
Wilkening A; Krappe J; Mühe AM; Lindenmeyer MT; Eltrich N; Luckow B; Vielhauer V
Nephrol Dial Transplant; 2020 Feb; 35(2):227-239. PubMed ID: 30597038
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
17. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
[No Abstract] [Full Text] [Related]
18. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
19. Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis.
Matoba K; Nagai Y; Sekiguchi K; Ohashi S; Mitsuyoshi E; Shimoda M; Tachibana T; Kawanami D; Yokota T; Utsunomiya K; Nishimura R
Commun Biol; 2024 Apr; 7(1):402. PubMed ID: 38565675
[TBL] [Abstract][Full Text] [Related]
20. Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes.
Barutta F; Kimura S; Hase K; Bellini S; Corbetta B; Corbelli A; Fiordaliso F; Barreca A; Papotti MG; Ghiggeri GM; Salvidio G; Roccatello D; Audrito V; Deaglio S; Gambino R; Bruno S; Camussi G; Martini M; Hirsch E; Durazzo M; Ohno H; Gruden G
J Am Soc Nephrol; 2021 May; 32(5):1114-1130. PubMed ID: 33722931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
